1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global CRISPR & Cas Genes Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Vector-based Cas 1.2.3 DNA-free Cas 1.2.4 Cell Line Engineering 1.3 Market by Application 1.3.1 Global CRISPR & Cas Genes Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Biotechnology and Pharmaceutical Companies 1.3.3 Academics and Government Research Institutes 1.3.4 Contract Research Organizations (CROs) 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global CRISPR & Cas Genes Market Perspective (2016-2027) 2.2 CRISPR & Cas Genes Growth Trends by Regions 2.2.1 CRISPR & Cas Genes Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 CRISPR & Cas Genes Historic Market Share by Regions (2016-2021) 2.2.3 CRISPR & Cas Genes Forecasted Market Size by Regions (2022-2027) 2.3 CRISPR & Cas Genes Industry Dynamic 2.3.1 CRISPR & Cas Genes Market Trends 2.3.2 CRISPR & Cas Genes Market Drivers 2.3.3 CRISPR & Cas Genes Market Challenges 2.3.4 CRISPR & Cas Genes Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top CRISPR & Cas Genes Players by Revenue 3.1.1 Global Top CRISPR & Cas Genes Players by Revenue (2016-2021) 3.1.2 Global CRISPR & Cas Genes Revenue Market Share by Players (2016-2021) 3.2 Global CRISPR & Cas Genes Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by CRISPR & Cas Genes Revenue 3.4 Global CRISPR & Cas Genes Market Concentration Ratio 3.4.1 Global CRISPR & Cas Genes Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by CRISPR & Cas Genes Revenue in 2020 3.5 CRISPR & Cas Genes Key Players Head office and Area Served 3.6 Key Players CRISPR & Cas Genes Product Solution and Service 3.7 Date of Enter into CRISPR & Cas Genes Market 3.8 Mergers & Acquisitions, Expansion Plans 4 CRISPR & Cas Genes Breakdown Data by Type 4.1 Global CRISPR & Cas Genes Historic Market Size by Type (2016-2021) 4.2 Global CRISPR & Cas Genes Forecasted Market Size by Type (2022-2027) 5 CRISPR & Cas Genes Breakdown Data by Application 5.1 Global CRISPR & Cas Genes Historic Market Size by Application (2016-2021) 5.2 Global CRISPR & Cas Genes Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America CRISPR & Cas Genes Market Size (2016-2027) 6.2 North America CRISPR & Cas Genes Market Size by Type 6.2.1 North America CRISPR & Cas Genes Market Size by Type (2016-2021) 6.2.2 North America CRISPR & Cas Genes Market Size by Type (2022-2027) 6.2.3 North America CRISPR & Cas Genes Market Size by Type (2016-2027) 6.3 North America CRISPR & Cas Genes Market Size by Application 6.3.1 North America CRISPR & Cas Genes Market Size by Application (2016-2021) 6.3.2 North America CRISPR & Cas Genes Market Size by Application (2022-2027) 6.3.3 North America CRISPR & Cas Genes Market Size by Application (2016-2027) 6.4 North America CRISPR & Cas Genes Market Size by Country 6.4.1 North America CRISPR & Cas Genes Market Size by Country (2016-2021) 6.4.2 North America CRISPR & Cas Genes Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe CRISPR & Cas Genes Market Size (2016-2027) 7.2 Europe CRISPR & Cas Genes Market Size by Type 7.2.1 Europe CRISPR & Cas Genes Market Size by Type (2016-2021) 7.2.2 Europe CRISPR & Cas Genes Market Size by Type (2022-2027) 7.2.3 Europe CRISPR & Cas Genes Market Size by Type (2016-2027) 7.3 Europe CRISPR & Cas Genes Market Size by Application 7.3.1 Europe CRISPR & Cas Genes Market Size by Application (2016-2021) 7.3.2 Europe CRISPR & Cas Genes Market Size by Application (2022-2027) 7.3.3 Europe CRISPR & Cas Genes Market Size by Application (2016-2027) 7.4 Europe CRISPR & Cas Genes Market Size by Country 7.4.1 Europe CRISPR & Cas Genes Market Size by Country (2016-2021) 7.4.2 Europe CRISPR & Cas Genes Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific CRISPR & Cas Genes Market Size (2016-2027) 8.2 Asia-Pacific CRISPR & Cas Genes Market Size by Type 8.2.1 Asia-Pacific CRISPR & Cas Genes Market Size by Type (2016-2021) 8.2.2 Asia-Pacific CRISPR & Cas Genes Market Size by Type (2022-2027) 8.2.3 Asia-Pacific CRISPR & Cas Genes Market Size by Type (2016-2027) 8.3 Asia-Pacific CRISPR & Cas Genes Market Size by Application 8.3.1 Asia-Pacific CRISPR & Cas Genes Market Size by Application (2016-2021) 8.3.2 Asia-Pacific CRISPR & Cas Genes Market Size by Application (2022-2027) 8.3.3 Asia-Pacific CRISPR & Cas Genes Market Size by Application (2016-2027) 8.4 Asia-Pacific CRISPR & Cas Genes Market Size by Region 8.4.1 Asia-Pacific CRISPR & Cas Genes Market Size by Region (2016-2021) 8.4.2 Asia-Pacific CRISPR & Cas Genes Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America CRISPR & Cas Genes Market Size (2016-2027) 9.2 Latin America CRISPR & Cas Genes Market Size by Type 9.2.1 Latin America CRISPR & Cas Genes Market Size by Type (2016-2021) 9.2.2 Latin America CRISPR & Cas Genes Market Size by Type (2022-2027) 9.2.3 Latin America CRISPR & Cas Genes Market Size by Type (2016-2027) 9.3 Latin America CRISPR & Cas Genes Market Size by Application 9.3.1 Latin America CRISPR & Cas Genes Market Size by Application (2016-2021) 9.3.2 Latin America CRISPR & Cas Genes Market Size by Application (2022-2027) 9.3.3 Latin America CRISPR & Cas Genes Market Size by Application (2016-2027) 9.4 Latin America CRISPR & Cas Genes Market Size by Country 9.4.1 Latin America CRISPR & Cas Genes Market Size by Country (2016-2021) 9.4.2 Latin America CRISPR & Cas Genes Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa CRISPR & Cas Genes Market Size (2016-2027) 10.2 Middle East & Africa CRISPR & Cas Genes Market Size by Type 10.2.1 Middle East & Africa CRISPR & Cas Genes Market Size by Type (2016-2021) 10.2.2 Middle East & Africa CRISPR & Cas Genes Market Size by Type (2022-2027) 10.2.3 Middle East & Africa CRISPR & Cas Genes Market Size by Type (2016-2027) 10.3 Middle East & Africa CRISPR & Cas Genes Market Size by Application 10.3.1 Middle East & Africa CRISPR & Cas Genes Market Size by Application (2016-2021) 10.3.2 Middle East & Africa CRISPR & Cas Genes Market Size by Application (2022-2027) 10.3.3 Middle East & Africa CRISPR & Cas Genes Market Size by Application (2016-2027) 10.4 Middle East & Africa CRISPR & Cas Genes Market Size by Country 10.4.1 Middle East & Africa CRISPR & Cas Genes Market Size by Country (2016-2021) 10.4.2 Middle East & Africa CRISPR & Cas Genes Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 CRISPR Therapeutics 11.1.1 CRISPR Therapeutics Company Details 11.1.2 CRISPR Therapeutics Business Overview 11.1.3 CRISPR Therapeutics CRISPR & Cas Genes Introduction 11.1.4 CRISPR Therapeutics Revenue in CRISPR & Cas Genes Business (2016-2021) 11.1.5 CRISPR Therapeutics Recent Development 11.2 AstraZeneca 11.2.1 AstraZeneca Company Details 11.2.2 AstraZeneca Business Overview 11.2.3 AstraZeneca CRISPR & Cas Genes Introduction 11.2.4 AstraZeneca Revenue in CRISPR & Cas Genes Business (2016-2021) 11.2.5 AstraZeneca Recent Development 11.3 Addgene 11.3.1 Addgene Company Details 11.3.2 Addgene Business Overview 11.3.3 Addgene CRISPR & Cas Genes Introduction 11.3.4 Addgene Revenue in CRISPR & Cas Genes Business (2016-2021) 11.3.5 Addgene Recent Development 11.4 Caribou Biosciences, Inc. 11.4.1 Caribou Biosciences, Inc. Company Details 11.4.2 Caribou Biosciences, Inc. Business Overview 11.4.3 Caribou Biosciences, Inc. CRISPR & Cas Genes Introduction 11.4.4 Caribou Biosciences, Inc. Revenue in CRISPR & Cas Genes Business (2016-2021) 11.4.5 Caribou Biosciences, Inc. Recent Development 11.5 Cellectis 11.5.1 Cellectis Company Details 11.5.2 Cellectis Business Overview 11.5.3 Cellectis CRISPR & Cas Genes Introduction 11.5.4 Cellectis Revenue in CRISPR & Cas Genes Business (2016-2021) 11.5.5 Cellectis Recent Development 11.6 Editas Medicine, Inc. 11.6.1 Editas Medicine, Inc. Company Details 11.6.2 Editas Medicine, Inc. Business Overview 11.6.3 Editas Medicine, Inc. CRISPR & Cas Genes Introduction 11.6.4 Editas Medicine, Inc. Revenue in CRISPR & Cas Genes Business (2016-2021) 11.6.5 Editas Medicine, Inc. Recent Development 11.7 Egenesis 11.7.1 Egenesis Company Details 11.7.2 Egenesis Business Overview 11.7.3 Egenesis CRISPR & Cas Genes Introduction 11.7.4 Egenesis Revenue in CRISPR & Cas Genes Business (2016-2021) 11.7.5 Egenesis Recent Development 11.8 F. Hoffmann-La Roche Ltd. 11.8.1 F. Hoffmann-La Roche Ltd. Company Details 11.8.2 F. Hoffmann-La Roche Ltd. Business Overview 11.8.3 F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Introduction 11.8.4 F. Hoffmann-La Roche Ltd. Revenue in CRISPR & Cas Genes Business (2016-2021) 11.8.5 F. Hoffmann-La Roche Ltd. Recent Development 11.9 Horizon Discovery Group Plc 11.9.1 Horizon Discovery Group Plc Company Details 11.9.2 Horizon Discovery Group Plc Business Overview 11.9.3 Horizon Discovery Group Plc CRISPR & Cas Genes Introduction 11.9.4 Horizon Discovery Group Plc Revenue in CRISPR & Cas Genes Business (2016-2021) 11.9.5 Horizon Discovery Group Plc Recent Development 11.10 Genscrip 11.10.1 Genscrip Company Details 11.10.2 Genscrip Business Overview 11.10.3 Genscrip CRISPR & Cas Genes Introduction 11.10.4 Genscrip Revenue in CRISPR & Cas Genes Business (2016-2021) 11.10.5 Genscrip Recent Development 11.11 Danaher Corporation 11.11.1 Danaher Corporation Company Details 11.11.2 Danaher Corporation Business Overview 11.11.3 Danaher Corporation CRISPR & Cas Genes Introduction 11.11.4 Danaher Corporation Revenue in CRISPR & Cas Genes Business (2016-2021) 11.11.5 Danaher Corporation Recent Development 11.12 Intellia Therapeutics, Inc. 11.12.1 Intellia Therapeutics, Inc. Company Details 11.12.2 Intellia Therapeutics, Inc. Business Overview 11.12.3 Intellia Therapeutics, Inc. CRISPR & Cas Genes Introduction 11.12.4 Intellia Therapeutics, Inc. Revenue in CRISPR & Cas Genes Business (2016-2021) 11.12.5 Intellia Therapeutics, Inc. Recent Development 11.13 Lonza 11.13.1 Lonza Company Details 11.13.2 Lonza Business Overview 11.13.3 Lonza CRISPR & Cas Genes Introduction 11.13.4 Lonza Revenue in CRISPR & Cas Genes Business (2016-2021) 11.13.5 Lonza Recent Development 11.14 Merck KGaA 11.14.1 Merck KGaA Company Details 11.14.2 Merck KGaA Business Overview 11.14.3 Merck KGaA CRISPR & Cas Genes Introduction 11.14.4 Merck KGaA Revenue in CRISPR & Cas Genes Business (2016-2021) 11.14.5 Merck KGaA Recent Development 11.15 New England BioLabs 11.15.1 New England BioLabs Company Details 11.15.2 New England BioLabs Business Overview 11.15.3 New England BioLabs CRISPR & Cas Genes Introduction 11.15.4 New England BioLabs Revenue in CRISPR & Cas Genes Business (2016-2021) 11.15.5 New England BioLabs Recent Development 11.16 Takara Bio, Inc. 11.16.1 Takara Bio, Inc. Company Details 11.16.2 Takara Bio, Inc. Business Overview 11.16.3 Takara Bio, Inc. CRISPR & Cas Genes Introduction 11.16.4 Takara Bio, Inc. Revenue in CRISPR & Cas Genes Business (2016-2021) 11.16.5 Takara Bio, Inc. Recent Development 11.17 Synthego 11.17.1 Synthego Company Details 11.17.2 Synthego Business Overview 11.17.3 Synthego CRISPR & Cas Genes Introduction 11.17.4 Synthego Revenue in CRISPR & Cas Genes Business (2016-2021) 11.17.5 Synthego Recent Development 11.18 Mammoth Biosciences 11.18.1 Mammoth Biosciences Company Details 11.18.2 Mammoth Biosciences Business Overview 11.18.3 Mammoth Biosciences CRISPR & Cas Genes Introduction 11.18.4 Mammoth Biosciences Revenue in CRISPR & Cas Genes Business (2016-2021) 11.18.5 Mammoth Biosciences Recent Development 11.18 Inscripta, Inc. .1 Inscripta, Inc. Company Details .2 Inscripta, Inc. Business Overview .3 Inscripta, Inc. CRISPR & Cas Genes Introduction .4 Inscripta, Inc. Revenue in CRISPR & Cas Genes Business (2016-2021) .5 Inscripta, Inc. Recent Development 11.20 Cibus 11.20.1 Cibus Company Details 11.20.2 Cibus Business Overview 11.20.3 Cibus CRISPR & Cas Genes Introduction 11.20.4 Cibus Revenue in CRISPR & Cas Genes Business (2016-2021) 11.20.5 Cibus Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global CRISPR & Cas Genes Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Vector-based Cas Table 3. Key Players of DNA-free Cas Table 4. Key Players of Cell Line Engineering Table 5. Global CRISPR & Cas Genes Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global CRISPR & Cas Genes Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global CRISPR & Cas Genes Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global CRISPR & Cas Genes Market Share by Regions (2016-2021) Table 9. Global CRISPR & Cas Genes Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global CRISPR & Cas Genes Market Share by Regions (2022-2027) Table 11. CRISPR & Cas Genes Market Trends Table 12. CRISPR & Cas Genes Market Drivers Table 13. CRISPR & Cas Genes Market Challenges Table 14. CRISPR & Cas Genes Market Restraints Table 15. Global CRISPR & Cas Genes Revenue by Players (2016-2021) & (US$ Million) Table 16. Global CRISPR & Cas Genes Market Share by Players (2016-2021) Table 17. Global Top CRISPR & Cas Genes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR & Cas Genes as of 2020) Table 18. Ranking of Global Top CRISPR & Cas Genes Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by CRISPR & Cas Genes Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players CRISPR & Cas Genes Product Solution and Service Table 22. Date of Enter into CRISPR & Cas Genes Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global CRISPR & Cas Genes Market Size by Type (2016-2021) (US$ Million) Table 25. Global CRISPR & Cas Genes Revenue Market Share by Type (2016-2021) Table 26. Global CRISPR & Cas Genes Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global CRISPR & Cas Genes Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global CRISPR & Cas Genes Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global CRISPR & Cas Genes Revenue Market Share by Application (2016-2021) Table 30. Global CRISPR & Cas Genes Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global CRISPR & Cas Genes Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America CRISPR & Cas Genes Market Size by Type (2016-2021) (US$ Million) Table 33. North America CRISPR & Cas Genes Market Size by Type (2022-2027) & (US$ Million) Table 34. North America CRISPR & Cas Genes Market Size by Application (2016-2021) (US$ Million) Table 35. North America CRISPR & Cas Genes Market Size by Application (2022-2027) & (US$ Million) Table 36. North America CRISPR & Cas Genes Market Size by Country (2016-2021) & (US$ Million) Table 37. North America CRISPR & Cas Genes Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe CRISPR & Cas Genes Market Size by Type (2016-2021) (US$ Million) Table 39. Europe CRISPR & Cas Genes Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe CRISPR & Cas Genes Market Size by Application (2016-2021) (US$ Million) Table 41. Europe CRISPR & Cas Genes Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe CRISPR & Cas Genes Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe CRISPR & Cas Genes Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific CRISPR & Cas Genes Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific CRISPR & Cas Genes Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific CRISPR & Cas Genes Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific CRISPR & Cas Genes Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific CRISPR & Cas Genes Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific CRISPR & Cas Genes Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America CRISPR & Cas Genes Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America CRISPR & Cas Genes Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America CRISPR & Cas Genes Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America CRISPR & Cas Genes Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America CRISPR & Cas Genes Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America CRISPR & Cas Genes Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa CRISPR & Cas Genes Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa CRISPR & Cas Genes Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa CRISPR & Cas Genes Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa CRISPR & Cas Genes Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa CRISPR & Cas Genes Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa CRISPR & Cas Genes Market Size by Country (2022-2027) & (US$ Million) Table 62. CRISPR Therapeutics Company Details Table 63. CRISPR Therapeutics Business Overview Table 64. CRISPR Therapeutics CRISPR & Cas Genes Product Table 65. CRISPR Therapeutics Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million) Table 66. CRISPR Therapeutics Recent Development Table 67. AstraZeneca Company Details Table 68. AstraZeneca Business Overview Table 69. AstraZeneca CRISPR & Cas Genes Product Table 70. AstraZeneca Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million) Table 71. AstraZeneca Recent Development Table 72. Addgene Company Details Table 73. Addgene Business Overview Table 74. Addgene CRISPR & Cas Genes Product Table 75. Addgene Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million) Table 76. Addgene Recent Development Table 77. Caribou Biosciences, Inc. Company Details Table 78. Caribou Biosciences, Inc. Business Overview Table 79. Caribou Biosciences, Inc. CRISPR & Cas Genes Product Table 80. Caribou Biosciences, Inc. Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million) Table 81. Caribou Biosciences, Inc. Recent Development Table 82. Cellectis Company Details Table 83. Cellectis Business Overview Table 84. Cellectis CRISPR & Cas Genes Product Table 85. Cellectis Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million) Table 86. Cellectis Recent Development Table 87. Editas Medicine, Inc. Company Details Table 88. Editas Medicine, Inc. Business Overview Table 89. Editas Medicine, Inc. CRISPR & Cas Genes Product Table 90. Editas Medicine, Inc. Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million) Table 91. Editas Medicine, Inc. Recent Development Table 92. Egenesis Company Details Table 93. Egenesis Business Overview Table 94. Egenesis CRISPR & Cas Genes Product Table 95. Egenesis Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million) Table 96. Egenesis Recent Development Table 97. F. Hoffmann-La Roche Ltd. Company Details Table 98. F. Hoffmann-La Roche Ltd. Business Overview Table 99. F. Hoffmann-La Roche Ltd. Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million) Table 100. F. Hoffmann-La Roche Ltd. Recent Development Table 101. Horizon Discovery Group Plc Company Details Table 102. Horizon Discovery Group Plc Business Overview Table 103. Horizon Discovery Group Plc CRISPR & Cas Genes Product Table 104. Horizon Discovery Group Plc Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million) Table 105. Horizon Discovery Group Plc Recent Development Table 106. Genscrip Company Details Table 107. Genscrip Business Overview Table 108. Genscrip CRISPR & Cas Genes Product Table 109. Genscrip Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million) Table 110. Genscrip Recent Development Table 111. Danaher Corporation Company Details Table 112. Danaher Corporation Business Overview Table 113. Danaher Corporation CRISPR & Cas Genes Product Table 114. Danaher Corporation Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million) Table 115. Danaher Corporation Recent Development Table 116. Intellia Therapeutics, Inc. Company Details Table 117. Intellia Therapeutics, Inc. Business Overview Table 118. Intellia Therapeutics, Inc. CRISPR & Cas Genes Product Table 119. Intellia Therapeutics, Inc. Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million) Table 120. Intellia Therapeutics, Inc. Recent Development Table 121. Lonza Company Details Table 122. Lonza Business Overview Table 123. Lonza CRISPR & Cas Genes Product Table 124. Lonza Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million) Table 125. Lonza Recent Development Table 126. Merck KGaA Company Details Table 127. Merck KGaA Business Overview Table 128. Merck KGaA CRISPR & Cas Genes Product Table 129. Merck KGaA Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million) Table 130. Merck KGaA Recent Development Table 131. New England BioLabs Company Details Table 132. New England BioLabs Business Overview Table 133. New England BioLabs CRISPR & Cas Genes Product Table 134. New England BioLabs Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million) Table 135. New England BioLabs Recent Development Table 136. Takara Bio, Inc. Company Details Table 137. Takara Bio, Inc. Business Overview Table 138. Takara Bio, Inc. CRISPR & Cas Genes Product Table 139. Takara Bio, Inc. Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million) Table 140. Takara Bio, Inc. Recent Development Table 141. Synthego Company Details Table 142. Synthego Business Overview Table 143. Synthego CRISPR & Cas Genes Product Table 144. Synthego Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million) Table 145. Synthego Recent Development Table 146. Mammoth Biosciences Company Details Table 147. Mammoth Biosciences Business Overview Table 148. Mammoth Biosciences CRISPR & Cas Genes Product Table 149. Mammoth Biosciences Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million) Table 150. Mammoth Biosciences Recent Development Table 151. Inscripta, Inc. Company Details Table 152. Inscripta, Inc. Business Overview Table 153. Inscripta, Inc. CRISPR & Cas Genes Product Table 154. Inscripta, Inc. Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million) Table 155. Inscripta, Inc. Recent Development Table 156. Cibus Company Details Table 157. Cibus Business Overview Table 158. Cibus CRISPR & Cas Genes Product Table 159. Cibus Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million) Table 160. Cibus Recent Development Table 161. Research Programs/Design for This Report Table 162. Key Data Information from Secondary Sources Table 163. Key Data Information from Primary Sources List of Figures Figure 1. Global CRISPR & Cas Genes Market Share by Type: 2020 VS 2027 Figure 2. Vector-based Cas Features Figure 3. DNA-free Cas Features Figure 4. Cell Line Engineering Features Figure 5. Global CRISPR & Cas Genes Market Share by Application: 2020 VS 2027 Figure 6. Biotechnology and Pharmaceutical Companies Case Studies Figure 7. Academics and Government Research Institutes Case Studies Figure 8. Contract Research Organizations (CROs) Case Studies Figure 9. CRISPR & Cas Genes Report Years Considered Figure 10. Global CRISPR & Cas Genes Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global CRISPR & Cas Genes Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global CRISPR & Cas Genes Market Share by Regions: 2020 VS 2027 Figure 13. Global CRISPR & Cas Genes Market Share by Regions (2022-2027) Figure 14. Global CRISPR & Cas Genes Market Share by Players in 2020 Figure 15. Global Top CRISPR & Cas Genes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR & Cas Genes as of 2020 Figure 16. The Top 10 and 5 Players Market Share by CRISPR & Cas Genes Revenue in 2020 Figure 17. Global CRISPR & Cas Genes Revenue Market Share by Type (2016-2021) Figure 18. Global CRISPR & Cas Genes Revenue Market Share by Type (2022-2027) Figure 19. North America CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America CRISPR & Cas Genes Market Share by Type (2016-2027) Figure 21. North America CRISPR & Cas Genes Market Share by Application (2016-2027) Figure 22. North America CRISPR & Cas Genes Market Share by Country (2016-2027) Figure 23. United States CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe CRISPR & Cas Genes Market Share by Type (2016-2027) Figure 27. Europe CRISPR & Cas Genes Market Share by Application (2016-2027) Figure 28. Europe CRISPR & Cas Genes Market Share by Country (2016-2027) Figure 29. Germany CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific CRISPR & Cas Genes Market Share by Type (2016-2027) Figure 37. Asia-Pacific CRISPR & Cas Genes Market Share by Application (2016-2027) Figure 38. Asia-Pacific CRISPR & Cas Genes Market Share by Region (2016-2027) Figure 39. China CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America CRISPR & Cas Genes Market Share by Type (2016-2027) Figure 47. Latin America CRISPR & Cas Genes Market Share by Application (2016-2027) Figure 48. Latin America CRISPR & Cas Genes Market Share by Country (2016-2027) Figure 49. Mexico CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa CRISPR & Cas Genes Market Share by Type (2016-2027) Figure 53. Middle East & Africa CRISPR & Cas Genes Market Share by Application (2016-2027) Figure 54. Middle East & Africa CRISPR & Cas Genes Market Share by Country (2016-2027) Figure 55. Turkey CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. CRISPR Therapeutics Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021) Figure 59. AstraZeneca Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021) Figure 60. Addgene Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021) Figure 61. Caribou Biosciences, Inc. Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021) Figure 62. Cellectis Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021) Figure 63. Editas Medicine, Inc. Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021) Figure 64. Egenesis Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021) Figure 65. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021) Figure 66. Horizon Discovery Group Plc Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021) Figure 67. Genscrip Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021) Figure 68. Danaher Corporation Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021) Figure 69. Intellia Therapeutics, Inc. Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021) Figure 70. Lonza Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021) Figure 71. Merck KGaA Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021) Figure 72. New England BioLabs Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021) Figure 73. Takara Bio, Inc. Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021) Figure 74. Synthego Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021) Figure 75. Mammoth Biosciences Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021) Figure 76. Inscripta, Inc. Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021) Figure 77. Cibus Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021) Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed

CRISPR Therapeutics AstraZeneca Addgene Caribou Biosciences, Inc. Cellectis Editas Medicine, Inc. Egenesis F. Hoffmann-La Roche Ltd. Horizon Discovery Group Plc Genscrip Danaher Corporation Intellia Therapeutics, Inc. Lonza Merck KGaA New England BioLabs Takara Bio, Inc. Synthego Mammoth Biosciences Inscripta, Inc. Cibus